Steroids for Treatment of COPD Exacerbations Less Is Clearly M...Chronic obstructive pulmonary disease (COPD) is a common, progressive lung condition, characterized by cough and dyspnea and punctuated by episodes of acute exacerbations or lung attacks during which these symptoms significantly increase. These lung ... Journal of the American Medical Association, 3 days ago
COPD-related depression, dyspnea disability improved by personalized program
- MedWire News, 1 month ago
|
7 images for dyspnea | ||||
Differentiating the Cause of Acute Dyspnea in the EDGeneral Medicine eJournal, 1 month ago |
Unruptured Aneurysm of the Sinus of Valsalva Presenting With Right Ventricular Outflow Tract Obstruction, Complete Heart Block, and Protrusion Into Left Ventricular Outflow Tract A Rare CombinationA 20-year-old male presented with exertional dyspnoea and exertional presyncope of 7 months duration, 1 episode of syncope 6 months ago with worsening dyspnea since 1 week. Examination revealed an ejection systolic murmur in the pulmonary area. The ... Journal of the American College of Cardiology, 2 weeks ago
|
A Thirty-Four-Year-Old Woman with Chronic Dyspnea and Pulmonary Interlobular Septal ThickeningIndividual Users: Register with Karger Login Information Please create your User ID & Password User ID Password Re-enter password Contact Information Title Name (*) First Name (*) E-Mail (*) Street Postcode City State Country Fax Telefon Mobile I ... Sexual Development, 2 weeks ago
|
Pulsatile Hemodynamics in Patients With Exertional Dyspnea Potentially of Value in the Diagnostic Evaluation of Suspected Heart Failure With Preserved Ejection FractionObjectives This study sought to test whether measures of pulsatile arterial function are useful for diagnosing heart failure with preserved ejection fraction (HFPEF), in comparison with and in addition to tissue Doppler echocardiography (TDE). Journal of the American College of Cardiology, 3 weeks ago
|
Method of treating dyspnea associated with acute heart failure by administering H2 relaxinThe disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation ... PharmCast, 4 weeks ago
|
Journal Scan: Anticoagulant rodenticide screening may help determine prognosisWhen a patient is presented for evaluation of lethargy, collapse, decreased appetite, vomiting, dyspnea, or coughing, you might suspect rodenticide exposure. Is it worth it to perform a screening for common anticoagulants to predict the prognosis? ... Thomson Veterinary Healthcare Communications, 1 month ago
|
Journal Scan: Using the vertebral heart scale to categorize dyspnea in catsResearchers evaluated the medical records of 67 cats that were presented over a one-year period for evaluation of acute onset of respiratory distress. Inclusion in the study required thoracic radiography and echocardiography, and the vertebral heart ... Thomson Veterinary Healthcare Communications, 1 month ago
|
Grand Rounds: Man, 57, With Dyspnea After Chiropractic Manipulation (Part 1)[ Full Text | Add to My Archive ] RELATED ARTICLE(S) Email Printer Friendly Order Reprints Share: Already a print Subscriber? Activate to get full subscriber access to our website. Missing and Damaged Issues Must be claimed within 3 months of ... Clinician Reviews, 1 month ago
|
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic CancerCelgene International Sàrl, a subsidiary of Celgene Corporation (Celgene) (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) for ... Quoteline, 2 days ago
5/23/13 - Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
Pharmacy Choice, 1 day ago
Oral Anti-Cancer Therapy REVLIMID(R) Receives Positive CHMP Opinion as Treatment for Patients with Form of Rare Blood Cancer Deletion 5Q Myelodysplastic Syndromes
Scottrade, 4 weeks ago
Oral Anti-Cancer Therapy REVLIMID® Receives Positive CHMP Opinion as Treatment for Patients with Form of Rare Blood Cancer Deletion 5Q Myelodysplastic Syndromes
PipelineReview, 3 weeks ago
|